Pharmaceuticals, Biotechnology and Life Sciences
N4 Pharma will test a Covid-19 DNA plasmid if Nuvec, a novel delivery system for cancer treatments and vaccines, can be used as a delivery system by potential collaboration partners developing Covid-19 DNA or RNA vaccines.
You want to do what is excellent for your kids. You know about the importance of baby gates, car seats, and other ways to keep them secure. But, did you know that the most excellent way to protect your kids is to make sure they have all of their vaccinations?
ObsEva CEO Ernest Loumaye s said the instituting new measures to support the priorities of safety to manage through the COVID-19 pandemic.
Teva said it will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month, to meet the urgent demand for the medicine as an investigational target to treat COVID-19.
Oxford Biomedica has signed a new Licence and Clinical Supply Agreement (LSA) with Bristol-Myers Squibb’s company, Juno Therapeutics to use Oxford Biomedica’s LentiVector platform for its application in CAR-T and TCR-T programmes in oncology and other indications.
BioNTech SE said Monday its development a potential vaccine to induce immunity and prevent COVID-19 infection in response to the growing global health threat posed by the disease has seen rapid progress. BioNTech’s product candidate, BNT162, is a potential first-in-class mRNA vaccine in the worldwide effort against COVID-19.
The World Health Organisation has issued a guideline to keep safety in schools. We have outlined the most important keys…
How do pharmaceutical companies prophet from COVID-19? Do they make the profit?
@augustfalleraugustfaller goes on tour with a seminar
GenomSys has moved two of its teams to the BioPôle in Lausanne, to support the company’s growth and improve its accessibility to the Life Sciences community.